XS
ABBV icon

XML Securities’s AbbVie ABBV Stock Holding History

XML Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$395K Sell
4,171
-368
-8% -$40.4K 0.49% 38
2017
Q4 		$439K Buy
+4,539
New +$428K 0.56% 39

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

XML Securities's ABBV Position: Q1 2018 in Review

XML Securities reduced its AbbVie (ABBV) stake by 8.1% in Q1 2018, selling an estimated $40.4K and leaving 4,171 shares worth $395K. The position accounts for 0.49% of the portfolio, ranked #38.

XML Securities first reported a position in ABBV in Q4 2017 and has held it in 2 quarters since. The position peaked at $439K in Q4 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • XML Securities held 4,171 shares of AbbVie worth $395K as of Q1 2018.
  • XML Securities sold 368 AbbVie shares in Q1 2018, an estimated $40.4K.
  • AbbVie made up 0.49% of XML Securities's portfolio in Q1 2018, its #38 holding.
  • XML Securities first reported a position in AbbVie in Q4 2017 and has held it in 2 quarters since.
  • XML Securities's AbbVie position peaked at $439K in Q4 2017.
  • 2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on XML Securities's 13F filing for Q1 2018, filed 17 May 2018.